G6PD Activator AG1 |
An activator of G6PDH (EC50 = 3.4 µM for G6PDHR459L); selectively in… |
1 mg |
39675-1 |
More Info
|
G6PD Activator AG1 |
An activator of G6PDH (EC50 = 3.4 µM for G6PDHR459L); selectively in… |
500 µg |
39675-500 |
More Info
|
G6PDi-1 |
An inhibitor of G6PDH; reduces NADPH levels in a variety of cultured cells… |
1 mg |
31484-1 |
More Info
|
G6PDi-1 |
An inhibitor of G6PDH; reduces NADPH levels in a variety of cultured cells… |
10 mg |
31484-10 |
More Info
|
G6PDi-1 |
An inhibitor of G6PDH; reduces NADPH levels in a variety of cultured cells… |
25 mg |
31484-25 |
More Info
|
G6PDi-1 |
An inhibitor of G6PDH; reduces NADPH levels in a variety of cultured cells… |
5 mg |
31484-5 |
More Info
|
GPP 78 |
A potent inhibitor of Nampt (IC50 = 3 nM); induces cell death in the neuro… |
1 mg |
13670-1 |
More Info
|
GPP 78 |
A potent inhibitor of Nampt (IC50 = 3 nM); induces cell death in the neuro… |
10 mg |
13670-10 |
More Info
|
GPP 78 |
A potent inhibitor of Nampt (IC50 = 3 nM); induces cell death in the neuro… |
5 mg |
13670-5 |
More Info
|
GPP 78 |
A potent inhibitor of Nampt (IC50 = 3 nM); induces cell death in the neuro… |
500 µg |
13670-500 |
More Info
|
GPR35 Blocking Peptide |
Peptide Sequence: human GPR35 · To be used in conjunction with Caym… |
1 ea |
10007661-1 |
More Info
|
GPR40 Blocking Peptide |
Peptide Sequence: human GPR40 amino acids 210-222 · To be used in c… |
1 ea |
10007206-1 |
More Info
|
GPR55 Blocking Peptide |
To be used in conjunction with Cayman's GPR55 Polyclonal Antibody to block… |
1 ea |
10225-200 |
More Info
|
GPR39-C3 |
A potent GPR39 agonist (EC50s = 0.8 and 0.4 nM for cAMP production in HEK2… |
1 mg |
25445-1 |
More Info
|
GPR39-C3 |
A potent GPR39 agonist (EC50s = 0.8 and 0.4 nM for cAMP production in HEK2… |
10 mg |
25445-10 |
More Info
|
GPR39-C3 |
A potent GPR39 agonist (EC50s = 0.8 and 0.4 nM for cAMP production in HEK2… |
25 mg |
25445-25 |
More Info
|
GPR39-C3 |
A potent GPR39 agonist (EC50s = 0.8 and 0.4 nM for cAMP production in HEK2… |
5 mg |
25445-5 |
More Info
|
GPR52 Comp-43 |
A GPR52 antagonist (IC50 = 0.63 µM); reduces mHTT protein levels in… |
10 mg |
33564-10 |
More Info
|
GPR52 Comp-43 |
A GPR52 antagonist (IC50 = 0.63 µM); reduces mHTT protein levels in… |
25 mg |
33564-25 |
More Info
|
GPR52 Comp-43 |
A GPR52 antagonist (IC50 = 0.63 µM); reduces mHTT protein levels in… |
5 mg |
33564-5 |
More Info
|
GPR52 Comp-43 |
A GPR52 antagonist (IC50 = 0.63 µM); reduces mHTT protein levels in… |
50 mg |
33564-50 |
More Info
|
GPR120 Compound A |
An orally available, selective agonist of GPR120 (EC50 = ~0.35 µM);… |
1 mg |
16624-1 |
More Info
|
GPR120 Compound A |
An orally available, selective agonist of GPR120 (EC50 = ~0.35 µM);… |
10 mg |
16624-10 |
More Info
|
GPR120 Compound A |
An orally available, selective agonist of GPR120 (EC50 = ~0.35 µM);… |
5 mg |
16624-5 |
More Info
|
GPR120 Compound A |
An orally available, selective agonist of GPR120 (EC50 = ~0.35 µM);… |
50 mg |
16624-50 |
More Info
|
GPR17 (C-Term) Blocking Peptide |
To block protein-antibody complex formation during immunochemical analysis… |
1 ea |
10345-200 |
More Info
|
GPX4 24 |
A GPX4 inhibitor; induces ferroptosis in GPX4-dependent HT-1080 cells (EC5… |
1 mg |
38428-1 |
More Info
|
GPX4 24 |
A GPX4 inhibitor; induces ferroptosis in GPX4-dependent HT-1080 cells (EC5… |
10 mg |
38428-10 |
More Info
|
GPX4 24 |
A GPX4 inhibitor; induces ferroptosis in GPX4-dependent HT-1080 cells (EC5… |
5 mg |
38428-5 |
More Info
|
GPX4 16 |
A GPX4 inhibitor; inhibits the proliferation of Nthy-ori-3-1, MDA-T32, and… |
1 mg |
40498-1 |
More Info
|
GPX4 16 |
A GPX4 inhibitor; inhibits the proliferation of Nthy-ori-3-1, MDA-T32, and… |
10 mg |
40498-10 |
More Info
|
GPX4 16 |
A GPX4 inhibitor; inhibits the proliferation of Nthy-ori-3-1, MDA-T32, and… |
5 mg |
40498-5 |
More Info
|
GPX4 Blocking Peptide |
Peptide Sequence: Human GPX4 amino acids 81-93 · To be used in conj… |
1 ea |
10005256-200 |
More Info
|
GPX1 (human, recombinant) |
Source: Active recombinant human GPX1 expressed in E. coli • Amino ac… |
100 µg |
39629-100 |
More Info
|
GPX1 (human, recombinant) |
Source: Active recombinant human GPX1 expressed in E. coli • Amino ac… |
50 µg |
39629-50 |
More Info
|
GPX2 (human, recombinant) |
Source: Active recombinant GPX2 expressed in E. coli • Amino acids: 1… |
100 µg |
39630-100 |
More Info
|
GPX2 (human, recombinant) |
Source: Active recombinant GPX2 expressed in E. coli • Amino acids: 1… |
50 µg |
39630-50 |
More Info
|
GPX4 (human, recombinant; His-tagged) |
Source: Active recombinant N-terminal His-tagged protein expressed in E. c… |
50 µg |
26906-50 |
More Info
|
GPX4 Inhibitor 26a |
A GPX4 inhibitor; inhibits GPX4 activity by 71.7% at 1 µM; cytotoxic… |
1 mg |
35408-1 |
More Info
|
GPX4 Inhibitor 26a |
A GPX4 inhibitor; inhibits GPX4 activity by 71.7% at 1 µM; cytotoxic… |
10 mg |
35408-10 |
More Info
|
GPX4 Inhibitor 26a |
A GPX4 inhibitor; inhibits GPX4 activity by 71.7% at 1 µM; cytotoxic… |
5 mg |
35408-5 |
More Info
|
GPX4 Inhibitor Screening Assay Kit |
Cayman's GPX4 Inhibitor Screening Assay Kit provides a robust and easy-to-… |
96 Well |
701880-96WELLS |
More Info
|
GQ-16 |
A partial agonist for PPARγ (Ki = 160 nM) which induces adipogenesis… |
10 mg |
11908-10 |
More Info
|
GQ-16 |
A partial agonist for PPARγ (Ki = 160 nM) which induces adipogenesis… |
100 mg |
11908-100 |
More Info
|
GQ-16 |
A partial agonist for PPARγ (Ki = 160 nM) which induces adipogenesis… |
5 mg |
11908-5 |
More Info
|
GQ-16 |
A partial agonist for PPARγ (Ki = 160 nM) which induces adipogenesis… |
50 mg |
11908-50 |
More Info
|
GR103691 |
A dopamine D3 receptor antagonist (Ki = 0.32 nM); selective for dopamine D… |
10 mg |
34870-10 |
More Info
|
GR103691 |
A dopamine D3 receptor antagonist (Ki = 0.32 nM); selective for dopamine D… |
25 mg |
34870-25 |
More Info
|
GR103691 |
A dopamine D3 receptor antagonist (Ki = 0.32 nM); selective for dopamine D… |
5 mg |
34870-5 |
More Info
|
GR103691 |
A dopamine D3 receptor antagonist (Ki = 0.32 nM); selective for dopamine D… |
50 mg |
34870-50 |
More Info
|